Cabana LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cabana LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1K	Buy	+8	New	+$788	﹤0.01%	164

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cabana LLC's XBI Position: Q2 2020 in Review

Cabana LLC opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2020: 8 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #164 among its holdings.

525 funds tracked by Wall St. Rank hold XBI as of Q2 2020.

Cabana LLC held 8 shares of State Street SPDR S&P Biotech ETF worth $1K as of Q2 2020.
State Street SPDR S&P Biotech ETF was a new Cabana LLC position in Q2 2020.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Cabana LLC's portfolio in Q2 2020, its #164 holding.
525 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2020.

Based on Cabana LLC's 13F filing for Q2 2020, filed 12 Aug 2020.